Bergen, Norway – Rare mutations in the amyloid precursor protein (APP) have previously been shown to be strongly associated with Alzheimer’s disease (AD)...
Ancona, Italy – Currently, no possibility exists to reliably quantify the risk of Alzheimer’s disease (AD) onset in the general population and in subjects with...
London, UK and Boston, USA – ÜberResearch and Altmetric, leading data and analytics companies serving scientific funders and research organizations, have...
Philadelphia, USA – Promising, early studies of deep brain stimulation (DBS) for the treatment of Alzheimer’s disease have paved a path for future clinical...
New York, USA – Huntington’s disease (HD) has no cure and no therapies to slow the course of this fatal disease. HD patients can experience a wide range of...
Morgantown, USA – In a recent study of adults with early memory loss, a West Virginia University research team lead by Dr. Kim Innes found that practice of a...
Duchenne muscular dystrophy (DMD), a progressive muscle disease affecting one in 3800-6300 live male births and leads to ambulatory loss, respiratory problems...
A discovery of high relevance in medical research will be published in Volume 55, number 4 of December 2016 of the prestigious “Journal of Alzheimer’s disease...
Bordeaux, France – A French observational study in real life showed that dementia patients benefiting from occupational therapy sessions report relevant...
Tests that measure the sense of smell may soon become common in neurologists’ offices. Scientists have been finding increasing evidence that the sense of smell...
An enzyme found in the fluid around the brain and spine is giving researchers a snapshot of what happens inside the minds of Alzheimer’s patients and how that...
